These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6981013)

  • 21. The role of fluorodeoxyglucose-positron emission tomography in the evaluation of seizure disorders.
    Theodore WH
    Semin Neurol; 1989 Dec; 9(4):301-6. PubMed ID: 2518339
    [No Abstract]   [Full Text] [Related]  

  • 22. Magnetic resonance and fluorine-18 deoxyglucose imaging in the investigation of a spinal cord tumor.
    Alavi A; Kramer E; Wegener W; Alavi J
    J Nucl Med; 1990 Mar; 31(3):360-4. PubMed ID: 2155315
    [No Abstract]   [Full Text] [Related]  

  • 23. [Localized imaging with 18F-fluorodeoxyglucose].
    Paul R; Ahonen A
    Duodecim; 1985; 101(12):1167-77. PubMed ID: 3874764
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of vascular activity in the determination of rate constants for the uptake of 18F-labeled 2-fluoro-2-deoxy-D-glucose: error analysis and normal values in older subjects.
    Evans AC; Diksic M; Yamamoto YL; Kato A; Dagher A; Redies C; Hakim A
    J Cereb Blood Flow Metab; 1986 Dec; 6(6):724-38. PubMed ID: 3491827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of cerebral glucose utilization in dementia.
    Matsuzawa T; Matsui H; Meguro K; Ueda M; Yamada K; Yamaguchi T; Itoh M; Hatazawa J; Kinomura S
    Sci Rep Res Inst Tohoku Univ Med; 1990 Dec; 37(1-4):11-21. PubMed ID: 2103655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
    J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positron emission tomography in diagnosing brainstem vascular lesions that cause abnormal eye movements.
    Kiyosawa M; Ishii K; Inoue C; Kawasaki T; Senda M
    Am J Ophthalmol; 1996 Oct; 122(4):557-67. PubMed ID: 8862054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain autoradiographic images from rats injected with both [18F]-fluorodeoxyglucose (FDG) and [14C]-glucose.
    Miller AL
    J Cereb Blood Flow Metab; 1989 Jun; 9(3):426-7. PubMed ID: 2715213
    [No Abstract]   [Full Text] [Related]  

  • 29. Two behavioral states studied in a single PET/FDG procedure: theory, method, and preliminary results.
    Chang JY; Duara R; Barker W; Apicella A; Finn R
    J Nucl Med; 1987 May; 28(5):852-60. PubMed ID: 3494830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of cerebral glucose metabolism using 18FDG and positron tomography in the neurologic investigation of the full term newborn infant.
    Thorp PS; Levin SD; Garnett ES; Nahmias C; Firnau G; Toi A; Upton AR; Nobbs PT; Sinclair JC
    Neuropediatrics; 1988 Aug; 19(3):146-53. PubMed ID: 3265490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18f-fluorodeoxyglucose method for measuring local cerebral glucose metabolism in man: technique and results.
    Reivich M; Alavi A; Greenberg J; Farkas T; Wolf A
    Prog Nucl Med; 1981; 7():138-48. PubMed ID: 7323304
    [No Abstract]   [Full Text] [Related]  

  • 32. Monitoring liver tumor therapy with [18F]FDG positron emission tomography.
    Nagata Y; Yamamoto K; Hiraoka M; Abe M; Takahashi M; Akuta K; Nishimura Y; Jo S; Masunaga S; Kubo S
    J Comput Assist Tomogr; 1990; 14(3):370-4. PubMed ID: 2335602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [F-18 FDG PET in dementia].
    Ichiya Y
    Rinsho Hoshasen; 1989 Oct; 34(11):1337-41. PubMed ID: 2601095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two behavioral states studied in a single PET/FDG procedure: error analysis.
    Chang JY; Duara R; Barker W; Apicella A; Yoshii F; Kelley RE; Ginsberg MD; Boothe TE
    J Nucl Med; 1989 Jan; 30(1):93-105. PubMed ID: 2783458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of deoxyglucose (DG) and fluorodeoxyglucose (FDG) metabolism in rat and ferret brain.
    Miller AL; Hawkins RA
    J Cereb Blood Flow Metab; 1990 Jan; 10(1):147-8. PubMed ID: 2298832
    [No Abstract]   [Full Text] [Related]  

  • 36. [Tomographic measurement of human cerebral glucose metabolism].
    Iwasaki Y; Konishi J; Makada Y; Yonekura Y
    Nihon Rinsho; 1991 Jul; 49(7):1528-31. PubMed ID: 1886247
    [No Abstract]   [Full Text] [Related]  

  • 37. Ringlike uptake of [18F]FDG in brain abscess: a PET study.
    Sasaki M; Ichiya Y; Kuwabara Y; Otsuka M; Tahara T; Fukumura T; Gunasekera R; Masuda K
    J Comput Assist Tomogr; 1990; 14(3):486-7. PubMed ID: 2335626
    [No Abstract]   [Full Text] [Related]  

  • 38. [Accumulation of fluorodeoxyglucose in ischemic myocardium. I. Comparison with myocardial perfusion at rest and during exercise].
    Yonekura Y; Senda M; Koide H; Saji H; Yamamoto K; Nishizawa S; Torizuka K; Fudo T; Hashimoto T; Kambara H
    Kaku Igaku; 1986 Oct; 23(10):1361-7. PubMed ID: 3493371
    [No Abstract]   [Full Text] [Related]  

  • 39. Special characteristics and potential for radiotracers for positron emission tomography.
    Fowler JS; Wolf AP
    Acupunct Electrother Res; 1981; 6(2-3):81-108. PubMed ID: 6120624
    [No Abstract]   [Full Text] [Related]  

  • 40. [Validity of positron emission tomography (PET) using 2-deoxy-2-[18F]fluoro-D-glucose (FDG) in patients with renal cell carcinoma (preliminary report)].
    Kawamura J; Hida S; Yoshida O; Yonekura Y; Senda M; Yamamoto K; Saji H; Fujita T; Konishi J
    Kaku Igaku; 1988 Oct; 25(10):1143-8. PubMed ID: 3265450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.